These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 27244897)

  • 1. Mesenchymal stem cell-like properties of CD133+ glioblastoma initiating cells.
    Pavon LF; Sibov TT; de Oliveira DM; Marti LC; Cabral FR; de Souza JG; Boufleur P; Malheiros SM; de Paiva Neto MA; da Cruz EF; Chudzinski-Tavassi AM; Cavalheiro S
    Oncotarget; 2016 Jun; 7(26):40546-40557. PubMed ID: 27244897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tropism of mesenchymal stem cell toward CD133
    Pavon LF; Sibov TT; de Souza AV; da Cruz EF; Malheiros SMF; Cabral FR; de Souza JG; Boufleur P; de Oliveira DM; de Toledo SRC; Marti LC; Malheiros JM; Paiva FF; Tannús A; de Oliveira SM; Chudzinski-Tavassi AM; de Paiva Neto MA; Cavalheiro S
    Stem Cell Res Ther; 2018 Nov; 9(1):310. PubMed ID: 30413179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin selectively affects human glioblastoma tumor-initiating cell viability: A role for metformin-induced inhibition of Akt.
    Würth R; Pattarozzi A; Gatti M; Bajetto A; Corsaro A; Parodi A; Sirito R; Massollo M; Marini C; Zona G; Fenoglio D; Sambuceti G; Filaci G; Daga A; Barbieri F; Florio T
    Cell Cycle; 2013 Jan; 12(1):145-56. PubMed ID: 23255107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD133+ glioblastoma stem-like cells induce vascular mimicry in vivo.
    Chiao MT; Yang YC; Cheng WY; Shen CC; Ko JL
    Curr Neurovasc Res; 2011 Aug; 8(3):210-9. PubMed ID: 21675958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gliosarcoma stem cells undergo glial and mesenchymal differentiation in vivo.
    deCarvalho AC; Nelson K; Lemke N; Lehman NL; Arbab AS; Kalkanis S; Mikkelsen T
    Stem Cells; 2010 Feb; 28(2):181-90. PubMed ID: 19937755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors.
    Liu Q; Nguyen DH; Dong Q; Shitaku P; Chung K; Liu OY; Tso JL; Liu JY; Konkankit V; Cloughesy TF; Mischel PS; Lane TF; Liau LM; Nelson SF; Tso CL
    J Neurooncol; 2009 Aug; 94(1):1-19. PubMed ID: 19468690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of CD133 and CD44 in glioblastoma stem cells correlates with cell proliferation, phenotype stability and intra-tumor heterogeneity.
    Brown DV; Filiz G; Daniel PM; Hollande F; Dworkin S; Amiridis S; Kountouri N; Ng W; Morokoff AP; Mantamadiotis T
    PLoS One; 2017; 12(2):e0172791. PubMed ID: 28241049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiologic oxygen concentration enhances the stem-like properties of CD133+ human glioblastoma cells in vitro.
    McCord AM; Jamal M; Shankavaram UT; Lang FF; Camphausen K; Tofilon PJ
    Mol Cancer Res; 2009 Apr; 7(4):489-97. PubMed ID: 19372578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Umbilical cord blood-derived mesenchymal stem cells consist of a unique population of progenitors co-expressing mesenchymal stem cell and neuronal markers capable of instantaneous neuronal differentiation.
    Divya MS; Roshin GE; Divya TS; Rasheed VA; Santhoshkumar TR; Elizabeth KE; James J; Pillai RM
    Stem Cell Res Ther; 2012 Dec; 3(6):57. PubMed ID: 23253356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bmi1 regulates human glioblastoma stem cells through activation of differential gene networks in CD133+ brain tumor initiating cells.
    Vora P; Seyfrid M; Venugopal C; Qazi MA; Salim S; Isserlin R; Subapanditha M; O'Farrell E; Mahendram S; Singh M; Bakhshinyan D; Chokshi C; McFarlane N; Dvorkin-Gheva A; Brown KR; Murty N; Moffat J; Bader GD; Singh SK
    J Neurooncol; 2019 Jul; 143(3):417-428. PubMed ID: 31115870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient generation of multipotent mesenchymal stem cells from umbilical cord blood in stroma-free liquid culture.
    Peters R; Wolf MJ; van den Broek M; Nuvolone M; Dannenmann S; Stieger B; Rapold R; Konrad D; Rubin A; Bertino JR; Aguzzi A; Heikenwalder M; Knuth AK
    PLoS One; 2010 Dec; 5(12):e15689. PubMed ID: 21209896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of in vitro driven expression signatures of CD133 stem cell marker and tumor stroma on clinical outcomes in gastric cancers.
    Kim TM; Ko YH; Ha SJ; Lee HH
    BMC Cancer; 2019 Feb; 19(1):119. PubMed ID: 30717708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD133/CD15 defines distinct cell subpopulations with differential in vitro clonogenic activity and stem cell-related gene expression profile in in vitro propagated glioblastoma multiforme-derived cell line with a PNET-like component.
    Kahlert UD; Bender NO; Maciaczyk D; Bogiel T; Bar EE; Eberhart CG; Nikkhah G; Maciaczyk J
    Folia Neuropathol; 2012; 50(4):357-68. PubMed ID: 23319191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis.
    Pallini R; Ricci-Vitiani L; Montano N; Mollinari C; Biffoni M; Cenci T; Pierconti F; Martini M; De Maria R; Larocca LM
    Cancer; 2011 Jan; 117(1):162-74. PubMed ID: 20806346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Gene Expression Profiling of Primary and Metastatic Renal Cell Carcinoma Stem Cell-Like Cancer Cells.
    Khan MI; Czarnecka AM; Lewicki S; Helbrecht I; Brodaczewska K; Koch I; Zdanowski R; Król M; Szczylik C
    PLoS One; 2016; 11(11):e0165718. PubMed ID: 27812180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-derived glioblastoma stem cells are killed by CD133-specific CAR T cells but induce the T cell aging marker CD57.
    Zhu X; Prasad S; Gaedicke S; Hettich M; Firat E; Niedermann G
    Oncotarget; 2015 Jan; 6(1):171-84. PubMed ID: 25426558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro Analysis of Neurospheres Derived from Glioblastoma Primary Culture: A Novel Methodology Paradigm.
    Pavon LF; Marti LC; Sibov TT; Malheiros SM; Brandt RA; Cavalheiro S; Gamarra LF
    Front Neurol; 2014 Jan; 4():214. PubMed ID: 24432012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coexpression analysis of CD133 and CD44 identifies proneural and mesenchymal subtypes of glioblastoma multiforme.
    Brown DV; Daniel PM; D'Abaco GM; Gogos A; Ng W; Morokoff AP; Mantamadiotis T
    Oncotarget; 2015 Mar; 6(8):6267-80. PubMed ID: 25749043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles.
    Beier D; Hau P; Proescholdt M; Lohmeier A; Wischhusen J; Oefner PJ; Aigner L; Brawanski A; Bogdahn U; Beier CP
    Cancer Res; 2007 May; 67(9):4010-5. PubMed ID: 17483311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial biological characterization of cancer stem-like cell line (WJ(2)) of human glioblastoma multiforme.
    Wang J; Wang X; Jiang S; Lin P; Zhang J; Wu Y; Xiong Z; Ren JJ; Yang H
    Cell Mol Neurobiol; 2008 Nov; 28(7):991-1003. PubMed ID: 18350379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.